| Financial Year |
March 31 2023 |
| Monetary Funds |
15,324,423,033.26 |
| Held-for-trading Financial Assets |
6,298,325,285.37 |
| Notes Receivable |
76,373,668.67 |
| Accounts Receivable |
5,551,794,490.44 |
| Advances to Suppliers |
384,849,980.13 |
| Other Receivables |
55,039,350.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,680,250,545.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
448,064,986.29 |
| Total Current Assets |
32,935,056,787.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
476,425,016.13 |
| Investment Properties |
324,559,790.05 |
| Fixed Assetes |
3,046,098,476.24 |
| Under-construction Projects |
494,656,200.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,256,502,763.39 |
| R&D expenses |
-- |
| Goodwill |
4,088,228.44 |
| Long-Term Deferred and Prepaid Expenses |
103,327,545.12 |
| Deferred Income Tax Assets |
184,337,808.15 |
| Other Non-Current Assets |
41,872,135.52 |
| Sub-Total of Non-Current Assets |
6,335,483,707.44 |
| Total Assets |
39,270,540,494.48 |
| Short-Term Loans |
1,565,887,354.53 |
| Trading Financial liabilities |
23,403,338.26 |
| Notes Payable |
3,603,000,968.32 |
| Accounts Payable |
6,053,163,510.30 |
| Accounts Received In Advance |
2,154,716.31 |
| Employee Compensation Payable |
816,973,912.53 |
| Taxes Payable |
654,699,549.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
152,848,277.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,293,250.79 |
| Other Current Liabilities |
55,345,961.91 |
| Sub-Total of Current Liabilities |
13,784,710,137.51 |
| Long-term Loans |
1,674,473,239.78 |
| Bonds Payable |
3,795,792,109.03 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,685,895.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,709,064,215.20 |
| Total Liabilities |
19,493,774,352.71 |
| Paid-In Capital(Or Share Stock) |
1,627,598,788.00 |
| Capital Surplus |
5,587,659,186.31 |
| Surplus Reserve |
536,996,294.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,222,167,012.63 |
| Minority Stockholder's Interest |
5,397,444,348.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,379,321,793.04 |
| Owner's Equity（Stockholder's Equity） |
19,776,766,141.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
39,270,540,494.48 |
